MedTrace Logo

Use of Fluorescein Dye for the Removal of Brain Tumors

NCT02389530 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 91

Last updated 2018-08-03

No results posted yet for this study

Summary

Fluorescein is a dye agent that can be injected through an intravenous line. It has been shown to help tell the difference between brain tumor tissue and normal brain tissue when it is used together with a specialized filter on a microscope in the operating room. The investigators plan to study the use of fluorescein in the removal of brain tumors at a low dose.

Conditions

  • Brain Neoplasms

Interventions

DRUG

Fluorescein

Fluorescein will be administered intravenously at a dose between 250 mg and 400 mg in the experimental arm.

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Johnathan Engh, MD · University of Pittsburgh Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389530 on ClinicalTrials.gov